Literature DB >> 902676

Plasma and intracellular kinetics of lithium after oral administration of various lithium salts.

A C Altamura, R Gomeni, E Sacchetti, E Smeraldi.   

Abstract

Five healthy volunteers were treated orally with lithium carbonate, sulphate, or chloride. There were no significant differences in area under time-concentration curves, half-lives, total body clearance or apparent distribution volumes between the various salts, either in plasma or in the RBC compartment. The carbonate salt did show a higher RBC/plasma distribution ratio than the other salts, which might possibly imply greater therapeutic effectiveness of this salt. Some considerations on the tolerability of various lithium salts are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 902676     DOI: 10.1007/bf00561406

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  Monitoring of lithium treatment through determination of lithium concentration.

Authors:  A Amdisen
Journal:  Dan Med Bull       Date:  1975-12

2.  Lithium salts in the treatment of psychotic excitement.

Authors:  J F J CADE
Journal:  Med J Aust       Date:  1949-09-03       Impact factor: 7.738

3.  Distribution of parenterally administered lithium in plasma, brain and muscle of rats.

Authors:  V D DAVENPORT
Journal:  Am J Physiol       Date:  1950-12

4.  Lithium carbonate absorption in humans.

Authors:  E T Sugita; J W Stokes; A Frazer; P Grof; J Mendels; F J Goldstein; P J Niebergall
Journal:  J Clin Pharmacol       Date:  1973-07       Impact factor: 3.126

5.  The prediction of brain lithium concentrations from plasma or erythrocyte measures.

Authors:  A Frazer; J Mendels; S K Secunda; C M Cochrane; C P Bianchi
Journal:  J Psychiatr Res       Date:  1973-06       Impact factor: 4.791

6.  Lithium carbonate toxicity.

Authors:  F A Herrero
Journal:  JAMA       Date:  1973-11-26       Impact factor: 56.272

Review 7.  Lithium in mania.

Authors:  S Gershon
Journal:  Clin Pharmacol Ther       Date:  1970 Mar-Apr       Impact factor: 6.875

8.  Double-blind comparison of lithium carbonate and imipramine in treatment of depression.

Authors:  S Watanabe; H Ishino; S Otsuki
Journal:  Arch Gen Psychiatry       Date:  1975-05

9.  A method for the determination of sodium, potassium, magnesium and lithium concentrations in erythrocytes.

Authors:  A Frazer; S K Secunda; J Mendels
Journal:  Clin Chim Acta       Date:  1972-02       Impact factor: 3.786

10.  Plasma renin activity in depressed patients treated with increasing doses of lithium carbonate.

Authors:  A C Altamura; A Morganti
Journal:  Psychopharmacologia       Date:  1975-12-31
View more
  5 in total

1.  A priori lithium dosage regimen using population characteristics of pharmacokinetic parameters.

Authors:  J Gaillot; J L Steimer; A J Mallet; J J Thebault; A Bieder
Journal:  J Pharmacokinet Biopharm       Date:  1979-12

2.  Distribution of lithium elimination rates in a selected population of psychiatric patients.

Authors:  D P Thornhill; S P Field
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 3.  Optimal frequency of lithium administration in the treatment of bipolar disorder: clinical and dosing considerations.

Authors:  Gin S Malhi; Michelle Tanious
Journal:  CNS Drugs       Date:  2011-04       Impact factor: 5.749

4.  Lithium pharmacokinetics: single-dose experiments and analysis using a physiological model.

Authors:  B E Ehrlich; C Clausen; J M Diamond
Journal:  J Pharmacokinet Biopharm       Date:  1980-10

5.  Effect of the Chronic Use of Lithium Carbonate on Induced Tooth Movement in Wistar Rats.

Authors:  Viviane da Silva Kagy; Luciana Trevisan Bittencourt Muniz; Arieli Carini Michels; Suelen Teixeira Luiz; Luciana Reis Azevedo Alanis; João Armando Brancher; Ana Maria Trindade Grégio; Sérgio Aparecido Ignácio; Elisa Souza Camargo; Maria Ângela Naval Machado; Aline Cristina Batista Rodrigues Johann
Journal:  PLoS One       Date:  2016-08-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.